In this study, we report that levels of D-2HG were significantly increased in the IDH mutant clinical samples similar to cultured glioma cells with IDH mutation, and that levels of intermediate metabolites such as those in the TCA cycle and ATP were altered, most likely through D-2HG activity. This evidence concerns the gene IDH1 and glioma.